Mutation analysis of the SPARC gene in the 5q- syndrome [3]

American Journal of Hematology

Volumn 64, Issue 4, 2000, Pages 324-

  Fidler, Carrie ^a   Strickson, Amanda ^a   Boultwood, Jackie ^a   Waincoat, James S ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

OSTEONECTIN;

CHROMOSOME 5Q; CLINICAL FEATURE; EXON; GENE LOSS; GENE SEQUENCE; GENETIC POLYMORPHISM; HUMAN; LETTER; MYELODYSPLASTIC SYNDROME; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

DNA MUTATIONAL ANALYSIS; FEMALE; HUMAN; MUTATION; MYELODYSPLASTIC SYNDROMES; OSTEONECTIN;

EID: 0033867816     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-8652(200008)64:4<324::AID-AJH19>3.0.CO;2-6     Document Type: Letter

References (5)

1. The 5q- syndrome
2. Molecular cytogenetic definition of the critical deleted region in the 5q- syndrome
3. Extracellular proteins that modulate cell-matrix interactions
4. Primary mesenchymal cells isolated from SPARC-null mice exhibit altered morphology and rates of proliferation
5. SPARC, an extracellular matrix protein with tumor-suppressing activity in human ovarian epithelial cells